• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在淀粉样变甲状腺素运载蛋白变体中,四聚体解离和单体部分解折叠先于原纤维形成。

Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants.

作者信息

Quintas A, Vaz D C, Cardoso I, Saraiva M J, Brito R M

机构信息

Centro de Neurociências de Coimbra, Universidade de Coimbra, 3004-517 Coimbra, the Instituto Superior de Ciências da Saúde Sul, Quinta da Granja, 2825 Monte da Caparica, Portugal.

出版信息

J Biol Chem. 2001 Jul 20;276(29):27207-13. doi: 10.1074/jbc.M101024200. Epub 2001 Apr 16.

DOI:10.1074/jbc.M101024200
PMID:11306576
Abstract

Amyloid fibril formation and deposition is a common feature of a wide range of fatal diseases including spongiform encephalopathies, Alzheimer's disease, and familial amyloidotic polyneuropathies (FAP), among many others. In certain forms of FAP, the amyloid fibrils are mostly constituted by variants of transthyretin (TTR), a homotetrameric plasma protein. Recently, we showed that transthyretin in solution may undergo dissociation to a non-native monomer, even under close to physiological conditions of temperature, pH, ionic strength, and protein concentration. We also showed that this non-native monomer is a compact structure, does not behave as a molten globule, and may lead to the formation of partially unfolded monomeric species and high molecular mass soluble aggregates (Quintas, A., Saraiva, M. J. M., and Brito, R. M. M. (1999) J. Biol. Chem. 274, 32943-32949). Here, based on aging experiments of tetrameric TTR and chemically induced protein unfolding experiments of the non-native monomeric forms, we show that tetramer dissociation and partial unfolding of the monomer precedes amyloid fibril formation. We also show that TTR variants with the least thermodynamically stable non-native monomer produce the largest amount of partially unfolded monomeric species and soluble aggregates under conditions that are close to physiological. Additionally, the soluble aggregates formed by the amyloidogenic TTR variants showed morphological and thioflavin-T fluorescence properties characteristic of amyloid. These results allowed us to conclude that amyloid fibril formation by some TTR variants might be triggered by tetramer dissociation to a compact non-native monomer with low conformational stability, which originates partially unfolded monomeric species with a high tendency for ordered aggregation into amyloid fibrils. Thus, partial unfolding and conformational fluctuations of molecular species with marginal thermodynamic stability may play a crucial role on amyloid formation in vivo.

摘要

淀粉样纤维的形成和沉积是多种致命疾病的共同特征,包括海绵状脑病、阿尔茨海默病和家族性淀粉样多神经病(FAP)等众多疾病。在某些形式的FAP中,淀粉样纤维主要由转甲状腺素蛋白(TTR)的变体构成,TTR是一种同四聚体血浆蛋白。最近,我们发现,即使在接近生理温度、pH、离子强度和蛋白质浓度的条件下,溶液中的转甲状腺素蛋白也可能解离为非天然单体。我们还发现,这种非天然单体是一种紧密结构,不像熔球态那样,可能会导致部分未折叠单体物种和高分子质量可溶性聚集体的形成(昆塔斯,A.,萨拉伊瓦,M. J. M.,和布里托,R. M. M.(1999年)《生物化学杂志》274卷,32943 - 32949页)。在此,基于四聚体TTR的老化实验和非天然单体形式的化学诱导蛋白质去折叠实验,我们表明,四聚体解离和单体的部分去折叠先于淀粉样纤维的形成。我们还表明,具有热力学上最不稳定非天然单体的TTR变体在接近生理的条件下产生的部分未折叠单体物种和可溶性聚集体数量最多。此外,由淀粉样变TTR变体形成的可溶性聚集体表现出淀粉样的形态和硫黄素 - T荧光特性。这些结果使我们得出结论,某些TTR变体形成淀粉样纤维可能是由四聚体解离为具有低构象稳定性的紧密非天然单体引发的,这种单体产生具有高度有序聚合成淀粉样纤维倾向的部分未折叠单体物种。因此,具有边缘热力学稳定性的分子物种的部分去折叠和构象波动可能在体内淀粉样形成中起关键作用。

相似文献

1
Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants.在淀粉样变甲状腺素运载蛋白变体中,四聚体解离和单体部分解折叠先于原纤维形成。
J Biol Chem. 2001 Jul 20;276(29):27207-13. doi: 10.1074/jbc.M101024200. Epub 2001 Apr 16.
2
The tetrameric protein transthyretin dissociates to a non-native monomer in solution. A novel model for amyloidogenesis.四聚体蛋白转甲状腺素蛋白在溶液中解离为非天然单体。一种淀粉样蛋白生成的新模型。
J Biol Chem. 1999 Nov 12;274(46):32943-9. doi: 10.1074/jbc.274.46.32943.
3
The amyloidogenic potential of transthyretin variants correlates with their tendency to aggregate in solution.转甲状腺素蛋白变体的淀粉样蛋白生成潜力与其在溶液中聚集的倾向相关。
FEBS Lett. 1997 Dec 1;418(3):297-300. doi: 10.1016/s0014-5793(97)01398-7.
4
Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation.通过分析超速离心法对转甲状腺素蛋白酸变性途径的表征:对野生型、V30M和L55P淀粉样原纤维形成的影响
Biochemistry. 1998 Dec 22;37(51):17851-64. doi: 10.1021/bi981876+.
5
The most pathogenic transthyretin variant, L55P, forms amyloid fibrils under acidic conditions and protofilaments under physiological conditions.最具致病性的转甲状腺素蛋白变体L55P,在酸性条件下形成淀粉样原纤维,在生理条件下形成原丝。
Biochemistry. 1999 Oct 12;38(41):13560-73. doi: 10.1021/bi991021c.
6
Transthyretin aggregation under partially denaturing conditions is a downhill polymerization.在部分变性条件下,转甲状腺素蛋白的聚集是一种下行聚合反应。
Biochemistry. 2004 Jun 15;43(23):7365-81. doi: 10.1021/bi049621l.
7
The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.甲状腺素运载蛋白的酸介导变性途径产生一种可自组装成淀粉样蛋白的构象中间体。
Biochemistry. 1996 May 21;35(20):6470-82. doi: 10.1021/bi952501g.
8
An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured.一种经改造的转甲状腺素蛋白单体,它不会形成淀粉样蛋白,除非它发生部分变性。
Biochemistry. 2001 Sep 25;40(38):11442-52. doi: 10.1021/bi011194d.
9
Comparison of lethal and nonlethal transthyretin variants and their relationship to amyloid disease.致死性和非致死性转甲状腺素蛋白变体的比较及其与淀粉样变性疾病的关系。
Biochemistry. 1995 Oct 17;34(41):13527-36. doi: 10.1021/bi00041a032.
10
Guanidine hydrochloride-induced denaturation and refolding of transthyretin exhibits a marked hysteresis: equilibria with high kinetic barriers.盐酸胍诱导的转甲状腺素蛋白变性和复性表现出明显的滞后现象:具有高动力学屏障的平衡。
Biochemistry. 1997 Aug 19;36(33):10230-9. doi: 10.1021/bi963195p.

引用本文的文献

1
Effect of G83R Mutation on Transthyretin Protein Structural Stability.G83R突变对转甲状腺素蛋白结构稳定性的影响。
ACS Omega. 2025 Aug 13;10(33):37674-37686. doi: 10.1021/acsomega.5c04236. eCollection 2025 Aug 26.
2
Unravelling the myriad physiologic roles of transthyretin: critical considerations for treating transthyretin amyloidosis.揭示甲状腺素运载蛋白的众多生理作用:治疗甲状腺素运载蛋白淀粉样变性的关键考量因素
Ann Med. 2025 Dec;57(1):2536755. doi: 10.1080/07853890.2025.2536755. Epub 2025 Jul 27.
3
Advances in the treatment of transthyretin amyloidosis.
转甲状腺素蛋白淀粉样变性病的治疗进展
eGastroenterology. 2025 Jul 18;3(3):e100198. doi: 10.1136/egastro-2025-100198. eCollection 2025.
4
Rationale and Design of ANTHOLOGY: An ATTR Amyloidosis Real-World Evidence Program Aiming to Address Gaps in Amyloidosis Care.ANTHOLOGY的原理与设计:一项旨在填补淀粉样变性病治疗空白的ATTR淀粉样变性病真实世界证据项目
Cardiol Ther. 2025 Mar 19. doi: 10.1007/s40119-025-00402-y.
5
Initiation of transthyretin aggregation at neutral pH by fluid agitation.通过液体搅拌在中性pH条件下引发转甲状腺素蛋白聚集。
Proc Natl Acad Sci U S A. 2025 Mar 18;122(11):e2425230122. doi: 10.1073/pnas.2425230122. Epub 2025 Mar 11.
6
Counter-diffusion studies of human transthyretin: the growth of high-quality crystals for X-ray and neutron crystallography.人转甲状腺素蛋白的逆流扩散研究:用于X射线和中子晶体学的高质量晶体的生长。
J Appl Crystallogr. 2025 Feb 1;58(Pt 1):107-118. doi: 10.1107/S1600576724011191.
7
Zn(ii)-driven impact of monomeric transthyretin on amyloid-β amyloidogenesis.锌离子驱动的单体甲状腺素运载蛋白对β-淀粉样蛋白淀粉样变的影响。
Chem Sci. 2025 Feb 4;16(10):4366-4373. doi: 10.1039/d4sc08771b. eCollection 2025 Mar 5.
8
Aggregation of Transthyretin by Fluid Agitation.通过液体搅拌使转甲状腺素蛋白聚集。
bioRxiv. 2024 Nov 11:2024.11.08.622726. doi: 10.1101/2024.11.08.622726.
9
Conformational Enigma of TDP-43 Misfolding in Neurodegenerative Disorders.神经退行性疾病中TDP-43错误折叠的构象之谜
ACS Omega. 2024 Sep 20;9(39):40286-40297. doi: 10.1021/acsomega.4c04119. eCollection 2024 Oct 1.
10
A Snapshot of the Most Recent Transthyretin Stabilizers.最新甲状腺素运载蛋白稳定剂概览
Int J Mol Sci. 2024 Sep 16;25(18):9969. doi: 10.3390/ijms25189969.